ArticleCancers2023
Primary and Secondary Tumors of the Parotid Gland: Clinical Features and Prognosis.
Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 14 citations in OpenAlex.
- Observable Classification Patterns and Diagnostic Uncertainty in Parotid Ultrasound: A Multimethod Secondary Analysis.Diagnostics (Basel, Switzerland) · 2026Article
- Article
- Article
- Clinicopathological Characteristics and Postoperative Outcomes Following Parotidectomy: A Ten-Year Retrospective Study from a Tertiary Center.Diseases (Basel, Switzerland) · 2026Article
- Personalized Strategies for Head and Neck Reconstruction Using Pedicled Flaps.Journal of personalized medicine · 2026Article
- Trends and Disparities in Mortality from Malignant Parotid Gland Tumors in the United States, 1999-2023: A Population-Based Analysis.Cancer informatics · 2026Article
- Immediate Facial Reanimation After Radical Parotidectomy for Malignancy: Oncologic Principles and Reconstructive Strategy.Clinical, cosmetic and investigational dermatology · 2026Review
- Fine-needle aspiration cytology reduces the frequency of surgeries for malignant salivary gland tumors.Cancer cytopathology · 2026Article
- Benign Epithelial Salivary Neoplasms: Single-Centered Histopathologic and Clinicodemographic Romanian Retrospective Study.Clinics and practice · 2025Article
- Parotid Gland Tumors: An Institutional 8-Year Retrospective Study Spanning the COVID-19 Pandemic and Global Diagnostic Trends.Journal of clinical medicine · 2025Article
- Nomogram based on immune-inflammatory indicators and age-adjusted charlson comorbidity index score to predict prognosis of postoperative parotid gland carcinoma patients.BMC oral health · 2024Article
- Long-term follow-up and prognostic analysis of parotid tumors in children and adolescents.Laryngoscope investigative otolaryngology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary and secondary malignant tumors can affect the parotid gland. The aim of this retrospective study was to evaluate the clinical features and prognosis of malignant epithelial tumors of the parotid gland. In particular, a comparison between primary and secondary cancer and survival analyses were performed. Eighteen patients with primary cancer and fifteen with intraparotid metastasis from cutaneous squamous cell carcinoma were included. A chart review was performed to collect clinical data (age, sex, smoking, alcohol consumption, tumor stage, type of surgical procedure, complications, recurrence and death). The majority of primary tumors were early (T1-2 N0, 83%) with mucoepidermoid carcinoma being the most common (33%). Secondary tumors were mostly staged P2 (53%) and N0 (67%). Subjects with secondary tumors were older than those with primary cancer. Post-operative permanent facial palsy was observed in 5 patients (17%) with primary cancer and 9 (60%) with secondary tumors (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.